SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-034128
Filing Date
2024-04-18
Accepted
2024-04-18 16:30:14
Documents
15
Period of Report
2024-04-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0204128-8k_optimizerx.htm   iXBRL 8-K 25168
2 PRESS RELEASE, DATED APRIL 16, 2024 ea020412801ex99-1_optimizerx.htm EX-99.1 135885
3 GRAPHIC ex99-1_001.jpg GRAPHIC 4361
  Complete submission text file 0001213900-24-034128.txt   356047

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE oprx-20240416.xsd EX-101.SCH 3021
5 XBRL LABEL FILE oprx-20240416_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE oprx-20240416_pre.xml EX-101.PRE 22363
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0204128-8k_optimizerx_htm.xml XML 3671
Mailing Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453
Business Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

IRS No.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38543 | Film No.: 24854647
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)